Last reviewed · How we verify
Adapalene and Benzoyl Peroxide Gel
Adapalene and Benzoyl Peroxide Gel is a Retinoid [EPC] Small molecule drug developed by Padagis LLC. It is currently FDA-approved. Also known as: Epiduo Gel.
At a glance
| Generic name | Adapalene and Benzoyl Peroxide Gel |
|---|---|
| Also known as | Epiduo Gel |
| Sponsor | Padagis LLC |
| Drug class | Retinoid [EPC] |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
- Dry Skin
- Contact Dermatitis
- Application Site Burning
- Application Site Irritation
- Skin Irritation
Serious adverse events
- Eyelid Edema
- Allergic Contact Dermatitis
- Throat Tightness
- Swelling Face
- Conjunctivitis
- Sunburn
- Blister
- Eczema
- Rash
- Pruritus
Key clinical trials
- Topical 5% Spironolactone Gel Versus 0.1% Adapalene Gel for Acne Vulgaris: A Randomized Split-Face Study (PHASE2)
- Evaluation of Topical Dutasteride as a Potential New Therapy for Facial Acne Vulgaris Versus the Triple Combination Therapy (Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel) (NA)
- Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgaris
- Experience With Topical Acne Treatment (EARLY_PHASE1)
- A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acne (PHASE4)
- A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris. (PHASE1)
- Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris (PHASE3)
- Long-term Study of Efficacy/Safety of Adapalene/Benzoyl Peroxide Topical Gel in Acne Vulgaris Subjects (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Adapalene and Benzoyl Peroxide Gel CI brief — competitive landscape report
- Adapalene and Benzoyl Peroxide Gel updates RSS · CI watch RSS
- Padagis LLC portfolio CI
Frequently asked questions about Adapalene and Benzoyl Peroxide Gel
What is Adapalene and Benzoyl Peroxide Gel?
Adapalene and Benzoyl Peroxide Gel is a Retinoid [EPC] drug developed by Padagis LLC.
Who makes Adapalene and Benzoyl Peroxide Gel?
Adapalene and Benzoyl Peroxide Gel is developed and marketed by Padagis LLC (see full Padagis LLC pipeline at /company/padagis-llc).
Is Adapalene and Benzoyl Peroxide Gel also known as anything else?
Adapalene and Benzoyl Peroxide Gel is also known as Epiduo Gel.
What drug class is Adapalene and Benzoyl Peroxide Gel in?
Adapalene and Benzoyl Peroxide Gel belongs to the Retinoid [EPC] class. See all Retinoid [EPC] drugs at /class/retinoid-epc.
What development phase is Adapalene and Benzoyl Peroxide Gel in?
Adapalene and Benzoyl Peroxide Gel is FDA-approved (marketed).
What are the side effects of Adapalene and Benzoyl Peroxide Gel?
Common side effects of Adapalene and Benzoyl Peroxide Gel include Dry Skin, Contact Dermatitis, Application Site Burning, Application Site Irritation, Skin Irritation. Serious adverse events: Eyelid Edema, Allergic Contact Dermatitis, Throat Tightness, Swelling Face.
Related
- Drug class: All Retinoid [EPC] drugs
- Manufacturer: Padagis LLC — full pipeline
- Also known as: Epiduo Gel
- Compare: Adapalene and Benzoyl Peroxide Gel vs similar drugs
- Pricing: Adapalene and Benzoyl Peroxide Gel cost, discount & access